Back to search

Article

Fixed Low-Dose Hydroxyurea Therapy: A Strategy for Reducing Emergency Room Visits and Improving Treatment Adherence in Paediatric Sickle Cell Anaemia in Resource-Limited Settings

2024-07-16

Abstract excerpt

<h4>Background: </h4> Sickle cell anaemia (SCA) is a prevalent genetic disorder in sub-Saharan Africa, characterised by frequent vaso-occlusive crises and other complications. Hydroxycarbamide (hydroxyurea) has proven effective in managing SCA but is underutilised in low- and middle-income countries (LMICs) due to cost and monitoring challenges. This study aims to ascertain the impact of a fixed low-dose hydroxyca...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
35f6c1b5-77cf-5ea7-9ee9-668121dbedbd
DOI
10.22541/au.172115069.98111347/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fixed Low-Dose Hydroxyurea Therapy: A Strategy for Reducing Emergency Room Visits and Improving Treatment Adherence in Paediatric Sickle Cell Anaemia in Resource-Limited SettingsDOI 10.22541/au.172115069.98111347/v1
Select a neighboring publication to make it the new centre.